A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

IsraelRecruitingPHASE2

Conditions

Locally Advanced Unresectable or Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma · Esophageal Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • City of Hope National Medical Center /ID# 268690, Duarte, California, United States

  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 272630, Irvine, California, United States

  • UCLA - Santa Monica /ID# 270024, Santa Monica, California, United States

  • AdventHealth Orlando /ID# 268561, Orlando, Florida, United States

  • City Of Hope - Atlanta. /ID# 280646, Newnan, Georgia, United States

  • Hattiesburg Clinic /ID# 268572, Hattiesburg, Mississippi, United States

  • Duke University Medical Center /ID# 268186, Durham, North Carolina, United States

  • Millennium Research & Clinical Development /ID# 268540, Houston, Texas, United States

  • Algemeen Ziekenhuis klina /ID# 268754, Brasschaat, Antwerpen, Belgium

  • Universitair Ziekenhuis Leuven /ID# 269957, Leuven, Vlaams-Brabant, Belgium

  • CHU de Liege /ID# 270223, Liège, Belgium

  • Princess Margaret Cancer Centre /ID# 268277, Toronto, Ontario, Canada

  • Centre Hospitalier de l'Universite de Montreal (CHUM) /ID# 268763, Montreal, Quebec, Canada

  • Jewish General Hospital /ID# 268413, Montreal, Quebec, Canada

  • Beijing Cancer Hospital /ID# 268455, Beijing, Beijing Municipality, China

  • Cancer Hospital Chinese Academy of Medical Sciences(Langfang) /ID# 277479, Langfang, Hebei, China

  • Harbin Medical University Cancer Hospital /ID# 268452, Harbin, Heilongjiang, China

  • Union Hospital - Tongji Medical College /ID# 268796, Wuhan, Hubei, China

  • The first Affiliated Hospital, Zhejiang University School of Medicine. /ID# 268782, Hangzhou, Zhejiang, China

  • Universitaetsklinikum Freiburg /ID# 270407, Freiburg im Breisgau, Baden-Wurttemberg, Germany

  • TUM Klinikum rechts der Isar /ID# 267792, Munich, Bavaria, Germany

  • Krankenhaus Nordwest /ID# 268462, Frankfurt am Main, Hesse, Germany

  • Universitaetsklinikum Leipzig /ID# 270432, Leipzig, Saxony, Germany

  • Haematologisch-Onkologische Praxis Eppendorf /ID# 268024, Hamburg, Germany

  • Meir Medical Center /ID# 267998, Kfar Saba, Central District, Israel

  • Soroka Medical Center /ID# 268301, Beersheba, Southern District, Israel

  • Tel Aviv Sourasky Medical Center /ID# 267755, Tel Aviv, Tel Aviv, Israel

  • Shaare Zedek Medical Center /ID# 267752, Jerusalem, Israel

  • Hadassah Medical Center-Hebrew University /ID# 267753, Jerusalem, Israel

  • Aichi Cancer Center /ID# 268124, Nagoya, Aichi-ken, Japan

  • National Cancer Center Hospital East /ID# 268083, Kashiwa-shi, Chiba, Japan

  • Shizuoka Cancer Center /ID# 268123, Sunto-gun, Shizuoka, Japan

  • National Cancer Center Hospital /ID# 268648, Chuo-Ku, Tokyo, Japan

  • The Cancer Institute Hospital Of JFCR /ID# 268656, Koto-ku, Tokyo, Japan

  • Pan American Center for Oncology Trials /ID# 268833, Rio Piedras, Puerto Rico

  • Hospital Universitario de Navarra /ID# 270119, Pamplona, Navarre, Spain

  • Hospital General Universitario Gregorio Maranon /ID# 270037, Madrid, Spain

  • Complexo Hospitalario Universitario de Ourense /ID# 270042, Ourense, Spain

  • Hospital Clinico Universitario de Valencia /ID# 270040, Valencia, Spain

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 267672, Kaohsiung City, Taiwan

  • China Medical University Hospital /ID# 267667, Taichung, Taiwan

  • National Cheng Kung University Hospital /ID# 267669, Tainan, Taiwan

  • National Taiwan University Hospital /ID# 267666, Taipei, Taiwan

  • Taipei Veterans General Hospital /ID# 267664, Taipei, Taiwan

  • Linkou Chang Gung Memorial Hospital /ID# 267668, Taoyuan City, Taiwan

  • Barts Health NHS Trust /ID# 270796, London, Greater London, United Kingdom

  • Oxford University Hospital NHS Trust /ID# 274614, Oxford, Oxfordshire, United Kingdom

  • Queen Elizabeth Hospital Birmingham /ID# 271199, Birmingham, United Kingdom

  • NHS Tayside Health Board /ID# 270799, Dundee, United Kingdom

Study leads
  • ABBVIE INC.

    Study Director

    AbbVie